BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 11489933)

  • 1. HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells.
    Llevadot J; Murasawa S; Kureishi Y; Uchida S; Masuda H; Kawamoto A; Walsh K; Isner JM; Asahara T
    J Clin Invest; 2001 Aug; 108(3):399-405. PubMed ID: 11489933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway.
    Dimmeler S; Aicher A; Vasa M; Mildner-Rihm C; Adler K; Tiemann M; Rütten H; Fichtlscherer S; Martin H; Zeiher AM
    J Clin Invest; 2001 Aug; 108(3):391-7. PubMed ID: 11489932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization.
    Takahashi T; Kalka C; Masuda H; Chen D; Silver M; Kearney M; Magner M; Isner JM; Asahara T
    Nat Med; 1999 Apr; 5(4):434-8. PubMed ID: 10202935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
    Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
    Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells.
    Asahara T; Takahashi T; Masuda H; Kalka C; Chen D; Iwaguro H; Inai Y; Silver M; Isner JM
    EMBO J; 1999 Jul; 18(14):3964-72. PubMed ID: 10406801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.
    Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB
    Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes.
    Assmus B; Urbich C; Aicher A; Hofmann WK; Haendeler J; Rössig L; Spyridopoulos I; Zeiher AM; Dimmeler S
    Circ Res; 2003 May; 92(9):1049-55. PubMed ID: 12676819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis.
    Masuda H; Kalka C; Takahashi T; Yoshida M; Wada M; Kobori M; Itoh R; Iwaguro H; Eguchi M; Iwami Y; Tanaka R; Nakagawa Y; Sugimoto A; Ninomiya S; Hayashi S; Kato S; Asahara T
    Circ Res; 2007 Sep; 101(6):598-606. PubMed ID: 17656679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells.
    Spyridopoulos I; Haendeler J; Urbich C; Brummendorf TH; Oh H; Schneider MD; Zeiher AM; Dimmeler S
    Circulation; 2004 Nov; 110(19):3136-42. PubMed ID: 15520325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia.
    Ruifrok WP; de Boer RA; Iwakura A; Silver M; Kusano K; Tio RA; Losordo DW
    Vasc Med; 2009 Feb; 14(1):29-36. PubMed ID: 19144777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo.
    Murayama T; Tepper OM; Silver M; Ma H; Losordo DW; Isner JM; Asahara T; Kalka C
    Exp Hematol; 2002 Aug; 30(8):967-72. PubMed ID: 12160849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decursin inhibits vasculogenesis in early tumor progression by suppression of endothelial progenitor cell differentiation and function.
    Jung SY; Choi JH; Kwon SM; Masuda H; Asahara T; Lee YM
    J Cell Biochem; 2012 May; 113(5):1478-87. PubMed ID: 22298358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction.
    Hamada H; Kim MK; Iwakura A; Ii M; Thorne T; Qin G; Asai J; Tsutsumi Y; Sekiguchi H; Silver M; Wecker A; Bord E; Zhu Y; Kishore R; Losordo DW
    Circulation; 2006 Nov; 114(21):2261-70. PubMed ID: 17088460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin improves the efficiency of endothelial progenitor cell therapy after myocardial infarction in mice: effects on transplanted cell survival and autologous endothelial progenitor cell mobilization.
    Cheng Y; Hu R; Lv L; Ling L; Jiang S
    J Surg Res; 2012 Jul; 176(1):e47-55. PubMed ID: 22595018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-18/interleukin-18 binding protein signaling modulates ischemia-induced neovascularization in mice hindlimb.
    Mallat Z; Silvestre JS; Le Ricousse-Roussanne S; Lecomte-Raclet L; Corbaz A; Clergue M; Duriez M; Barateau V; Akira S; Tedgui A; Tobelem G; Chvatchko Y; Lévy BI
    Circ Res; 2002 Sep; 91(5):441-8. PubMed ID: 12215494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate to high concentrations of high-density lipoprotein from healthy subjects paradoxically impair human endothelial progenitor cells and related angiogenesis by activating Rho-associated kinase pathways.
    Huang CY; Lin FY; Shih CM; Au HK; Chang YJ; Nakagami H; Morishita R; Chang NC; Shyu KG; Chen JW
    Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2405-17. PubMed ID: 22904272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
    Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway.
    Han JK; Lee HS; Yang HM; Hur J; Jun SI; Kim JY; Cho CH; Koh GY; Peters JM; Park KW; Cho HJ; Lee HY; Kang HJ; Oh BH; Park YB; Kim HS
    Circulation; 2008 Sep; 118(10):1021-33. PubMed ID: 18711014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury.
    Iwakura A; Luedemann C; Shastry S; Hanley A; Kearney M; Aikawa R; Isner JM; Asahara T; Losordo DW
    Circulation; 2003 Dec; 108(25):3115-21. PubMed ID: 14676142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dosage of simvastatin reduces TNF-alpha-induced apoptosis of endothelial progenitor cells but fails to prevent apoptosis induced by IL-1beta in vitro.
    Henrich D; Seebach C; Wilhelm K; Marzi I
    J Surg Res; 2007 Sep; 142(1):13-9. PubMed ID: 17716606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.